Annals of Human Genetics

Ann Hum Genet

0003-4800

1469-1809

Therapeutic Area

Biology, Genomics, Molecular Medicine, Pharmacogenetics & Pharmacogenomics, Research, Statistics

Biologists, Cell Biologists, Molecular Biologists, Researchers, Scientists, Statisticians

Annals of Human Genetics publishes material directly concerned with human genetics or the application of scientific principles and techniques to any aspect of human inheritance. Papers that describe work on other species that may be relevant to human genetics will also be considered. Mathematical models should include examples of application to data where possible. Authors are welcome to submit Supporting Information, such as data sets or additional figures or tables, that will not be published in the print edition of the journal, but which will be viewable via the online edition and stored on the website. The Annals of Human Genetics is an international journal publishing rigorously peer-reviewed research. The principal aim of the Annals is to increase understanding of the causes and consequences of human genetic variation, particularly in relation to health, disease and evolution. The major topics covered in the Annals include:- Human genome variation – its evolution and implications for human biology. Interpretations of the past, current or future state of the human genome sequence, including ancient DNA studies, are also welcomed. Human population and evolutionary genetics – including studies aimed at inferring human demographic and adaptation history, at improving our understanding of chromosome evolution, and at describing the geographic distribution of biologically/medically-relevant genetic variation, worldwide. Statistical genetics – the application and improvement of mathematical approaches for analysis of genetic data, including linkage and association mapping of genes and QTLs. The journal also welcomes papers focussing on more general bioinformatic developments. Genetics of common multifactorial diseases and other complex traits – in general we expect these to be human but relevant animal models will also be considered. We also publish meta-analyses, provided they conform to specified requirements. Mendelian disorders and rare variant effects – including studies exploring the effects of DNA changes and chromosomal abnormalities on cell biology and on phenotype. Animal and in vitro studies - relevant non-human studies will be considered including animal models of human disease, explorations of mechanisms underlying genetic effects on human phenotypes and genetics of human pathogens. RNA studies - studies relevant to humans which investigate the effects of genetic variation on gene expression and which investigate the functioning of RNA in biological processes. Pharmacogenomics - studies of effects of genetic variation on efficacy or tolerability of drug treatments. Cancer genetics - relationship of germline and somatic variants to cancer risk and responses to treatment. Clinical genetics - we will consider accounts of clinical applications of scientific advances in genetics and of clinical findings which provide important new knowledge applicable beyond the context of the individual patient. Social and ethical issues - we welcome submissions addressing the role of genetics in society and challenging or controversial issues arising from clinical and non-clinical aspects of the implementation of genetic technologies.

No associations affiliated with this journal

Wiley-Blackwell

Impact Factor JCR Categories/Rank Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines